Zobrazeno 11 - 20
of 5 314
pro vyhledávání: '"Frank, V."'
Publikováno v:
Tropicultura, Vol 9, Iss 2, Pp 69-76 (1991)
Lake Ihema fishery (Rwanda). Commercial production and socio-economical profitability (1981-1987). Among the small lakes in the flooded area of the river Akagera, in eastern Rwanda, lake Ihema (area : 90 km2, mean depth : 4 m) is the most important.
Externí odkaz:
https://doaj.org/article/06605399c67147cd8425c6511bb746e6
Autor:
Chang, Joe Y *, Lin, Steven H, Dong, Wenli, Liao, Zhongxing, Gandhi, Saumil J, Gay, Carl M, Zhang, Jianjun, Chun, Stephen G, Elamin, Yasir Y, Fossella, Frank V, Blumenschein, George, Cascone, Tina, Le, Xiuning, Pozadzides, Jenny V, Tsao, Anne, Verma, Vivek, Welsh, James W, Chen, Aileen B, Altan, Mehmet, Mehran, Reza J, Vaporciyan, Ara A, Swisher, Stephen G, Balter, Peter A, Fujimoto, Junya, Wistuba, Ignacio I, Feng, Lei, Lee, J Jack, Heymach, John V
Publikováno v:
In The Lancet 9-15 September 2023 402(10405):871-881
Autor:
Mills, Sophie K., Rotger, Andreu, Brooks, Annabelle M.L., Paladino, Frank V., Robinson, Nathan J.
Publikováno v:
In Journal of Experimental Marine Biology and Ecology September 2023 566
Autor:
Cespedes, Frank V.1, Krentzel, Georg2
Publikováno v:
Harvard Business Review Digital Articles. 3/7/2024, p1-8. 8p.
Autor:
Yildiz, Mehmet, Miedema, Michael D., Murthy, Avinash, Henry, Timothy D., Bergstedt, Seth, Okeson, Brynn K., Schmidt, Christian W., Volpenhein, Lucas, Garcia, Santiago, Sharkey, Scott W., Aguirre, Frank V.
Publikováno v:
In Heliyon June 2023 9(6)
Autor:
Frank V. Celeste, Scott Powers
Publikováno v:
Cancers, Vol 16, Iss 5, p 1001 (2024)
Drug resistance can evolve from a subpopulation of cancer cells that initially survive drug treatment and then gradually form a pool of drug-tolerant cells. Several studies have pinpointed the activation of a specific bypass pathway that appears to p
Externí odkaz:
https://doaj.org/article/d5d40e58619c44389fa41728814ad615
Autor:
Kaiwen Wang, PharmD, Robyn Du, BS, Sinchita Roy-Chowdhuri, MD, Ziping T. Li, MD, Lingzhi Hong, MD, Natalie Vokes, MD, Yasir Y. Elamin, MD, Celyne Bueno Hume, MD, Ferdinandos Skoulidis, MD, PhD, Carl M. Gay, MD, PhD, George Blumenschein, MD, Frank V. Fossella, MD, Anne Tsao, MD, Jianjun Zhang, MD, PhD, Niki Karachaliou, MD, Aurora O’Brate, PhD, Claudia-Nanette Gann, MD, Jeff Lewis, MS, Waree Rinsurongkawong, PhD, J. Jack Lee, PhD, MS, DDS, Don Lynn Gibbons, MD, PhD, Ara A. Vaporciyan, MD, John V. Heymach, MD, PhD, Mehmet Altan, MD, Xiuning Le, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 8, Pp 100533- (2023)
Introduction: MET amplification is a known resistance mechanism to EGFR tyrosine kinase inhibitor (TKI) treatment in EGFR-mutant NSCLC. Dual EGFR-MET inhibition has been reported with success in overcoming such resistance and inducing clinical benefi
Externí odkaz:
https://doaj.org/article/abe6440483814bd08d4c9b73ab459684
Autor:
Mehmet Yildiz, Michael D. Miedema, Avinash Murthy, Timothy D. Henry, Seth Bergstedt, Brynn K. Okeson, Christian W. Schmidt, Lucas Volpenhein, Santiago Garcia, Scott W. Sharkey, Frank V. Aguirre
Publikováno v:
Heliyon, Vol 9, Iss 6, Pp e17308- (2023)
Although there is an established association between elevated triglyceride (eTG, ≥175 mg/dl) levels and adverse cardiovascular events, some studies have suggested that eTG levels may be linked to neutral or even improved clinical outcomes, particul
Externí odkaz:
https://doaj.org/article/8d51b19265574a2eba8e64daa1a0edd0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.